About

The Medical Team

Inspiring Better Health

In-house specialists

ZELL-V Wellness hub adopts a medical-science approach in the areas of health assessment, detoxification, boosting and rejuvenation, supported by a medical unit headed by in-house specialists:

Medical Advisory Board

A Medical Advisory Board was established to provide core support for our in-house medical unit. Some well-respected doctors from the board include:

Close

Dr Helmut Brammer

  • President of the German Society for Thymus Therapy
  • Founder of the German Medical Society for Chelation Therapy

Medical Specialties

Cell Therapy, Surgery, Internal Medicine, Homeopathy, Psychotherapy


Honours

Dr Brammer has practised Cell Therapy for more than 30 years for various indications and has achieved amazing results. He has successfully utilised Lyophilised Fresh Cells (L.F.C. Therapy) to improve the lives of patients suffering from so called incurable diseases or just the usual ailments of ageing. In honour of his achievements Dr Brammer is now the President of the German Society for Thymus Therapy, Germany.

He also specialises in psychotherapy, natural healing and homeopathy, wrote and published scientific articles, books and conducted hundreds of lectures on rejuvenation and anti-ageing therapy. Dr Brammer is the founder of several medical associations, including the German Medical Society for Chelation Therapy in Germany.

Close

Dr Ursula Jacob

  • Medical Specialist in General Medicine
  • Owner of Private Hospital Dr Ursula Jacob GmbH

Medical Specialties

Cell Therapy, Surgery, Internal Medicine, Emergency Medicine, Haematology, Homeopathy


Honours

Dr Ursula Jacob has practiced Rejuvenation Medicine for more than 20 years. After serving several years in various medical establishments, Dr Jacob is now the proud founder and owner of Private Hospital Dr Ursula Jacob GmbH in Hallwangen, Germany, specialising in cell therapy and homeopathy for rejuvenation and anti-ageing. Dr Jacob is a keen researcher in stem cells, cell extracts as well as growth factors and has achieved several outstanding results in the treatment of degenerative diseases. Dr Jacob has also successfully utilised cell therapy to improve the quality of life of people from different age groups.

Close

Dr Albert Schmierer

  • Researcher in Cell Mitochondrial and Homeopathic treatments
  • Owner & CEO of Dr Zinsser Pharmaceuticals
  • Owner of Neckartor-Apotheke

Medical Specialties

Cell Therapy, Homeopathy, Pharmacology


Honours

Dr Albert Schmierer is one of the leading German researchers in the field of new cell mitochondrial as well as homeopathic treatments. He successfully combines his knowledge in both mitochondrial and homeopathic research and treatment.

Dr Schmierer has a keen interest in anti-ageing medicine, including cell therapy with the emphasis in cell mitochondrial treatment for rejuvenation, regeneration and fighting premature ageing.

Dr Schmierer is also the chief pharmacist for mitochondrial and homeopathic therapy at the Private Hospital Dr Ursula Jacob GmbH as well as the owner and CEO of Dr Zinsser Pharmaceuticals (Research and Production of homeopathic potencies since 1958 in Germany).

Close

DR ULRICH FRIEDRICHSON M.D.PH.D.

  • Medical Doctor & Researcher in Cellular Therapy & Gene Therapy
  • Medical Director & Owner of Praxis Hospital Friedrichson

Medical Specialties

Cellular Therapy, Gene Therapy, Biochemistry, Preventive & Regenerative Medicine


Honours

Dr Friedrichson has been doing research and treatment with embryonic and foetal cell extract therapy as well as whole cell therapy for anti-ageing medicine, cancer, chronic fatigue syndrome, chronic neurological diseases and other degenerative diseases since 1976. He prescribes Special Purpose Applications (S.P.A.) according to the needs or requests of individuals requiring specific treatments. S.P.A. is a combination of various cells in vials which are prepared to focus on rejuvenating and regenerating specific systems of the body. Dr Friedrichson believes that the integration of natural medicine, cell therapy and modern medicine are effective in his treatments.

Through his unending pursuit of education, private research and development, Dr. Friedrichson has over the years developed a reputation in the European Society of biological Tumortherapy, German Psycho-social-oncology society, German Society of Anti-Ageing Medicine, American Society of Clinical Oncology and International Academy of Alternative and Anti-Ageing Medicine, just to name a few.

Close

DR YAROSLAV VASILCISIN

  • Orthopaedic Surgeon and Traumatologist

Medical Specialties

Traumatology, Orthopaedics, Neurosurgery


Honours

Dr Yaroslav Vasilcisin is a leading specialist in hip and knee arthroplasty and has pioneered various operative interventions of the hip, knee and spine.

He graduated from the Chernivtsi State Medical Institute in 1996 and served his internship at the institute’s Traumatology, Orthopaedics and Neurosurgery Department in 1996-1998. In 2003, he took on the position as Chief Physician of the Centre for Traumatology and Orthopaedics, Swedish-Ukrainian Mezhitsinsky Centre Angelholm. In 2008, he received his academic title – Candidate of Medical Sciences and was conferred the “Honoured Doctor of Ukraine” title by the Decree of the President of Ukraine for medical achievements in the field of traumatology, orthopaedics and neurosurgery. Since 2013, he has taken the role as Associate Professor of the Department of Traumatology, Orthopaedics and Neurosurgery, Bukovina State Medical University.

Dr Yaroslav Vasilcisin is repeatedly trained in leading medical centres in Sweden, Germany, USA, France and Italy, and has performed more than 8,000 complex surgical interventions. He is also the author of two monographs, 15 scientific papers, six patents and copyright certificates for inventions.

Close

DR MICHAEL MÄNNEL

  • Medical Doctor and Researcher in Cellular Therapy and Molecular Biology

Medical Specialties

Naturopathy, Internal Medicine, Complementary Oncology, Organ Cell Therapy, Knee Injury, ENT, Degenerative Diseases and Chronic Fatigue Syndrome


Honours

Dr Michael Männel is an outstanding naturopathic, internist and complementary oncologist with over 40 years of experience in organ cell therapy, knee injury, ENT, degenerative diseases and chronic fatigue syndrome. He has been working intensively on organ cell therapy and its immunological activities. In 1974, he started his own practice in gastroenterology, accident surgery and complementary oncology.

He has conducted countless lectures in many large cities in Germany, the Netherlands and Austria, as well as in London and Bangkok. In addition, he has been offering cellular therapy consultation worldwide since 2002.

He has authored many publications about xenogenic organo-therapies (multiple), laser applications, bioresonance and MGUS (monoclonal gammopathy unclear significance, the precursor/precancerous disease of multiple myeloma).

He is also the author of “Angewandte Onko-Immunologie” (1st edition 2003, 6th edition 2008), “Therapy-Fibers of Xenogenic OrganoPeptides” (1st edition 2015, 2nd edition 2016) and “Therapy Guide of Xenogenic Organo-cell Therapies – Special for Asia and the Middle East”(1st edition 2017).

Close

DR HARALD LEHMANN

  • Orthopaedic Surgeon and Traumatologist

Medical Specialties

Orthopaedics, Orthopaedic Surgery, Orthopaedic Rheumatology, Traumatology, Sport Medicine, Acupuncture


Honours

Dr Harald Lehmann has over 28 years of extensive experience in orthopaedics. Since 2002, he has started his own medical practice in orthopaedics and traumatology in Berlin, Germany. He also performs orthopaedic surgery in Oberlinclinic (specialised clinic for orthopaedics) in Potsdam, Germany. He is proficient in various musculoskeletal therapies and has helped thousands of people obtain relief from muscular and joint pain, and regain their mobility and freedom.

Close

DR DHEYAA ALI HUSSEIN AL SULTANI

  • General Surgeon Consultant and Cellular Therapy Expert

Medical Specialties

General Surgery


Honours

Dr Dheyaa is a board certified surgeon specialising in general surgery with strong record of success in treating advanced conditions including diabetes mellitus and cardiovascular via cellular therapy.

He graduated from the College of Medicine, Baghdad, Iraq in 1992 and served his internship at Al Hillah Teaching Hospital in 1992-1995. In 2006, he took on the position as head of general surgery emergency department at the Al Hillah Teaching Hospital. He became a senior trainer at the Arab Board Programme in Al Hillah since 2009.

Dr Dheyaa is repeatedly trained in leading medical centres in Iraqi, New Delhi, Babylon, Malaysia, etc. He has published 3 research papers on colonic injuries, paediatric bleeding rectum and emergency laparotomy.

Close

DR MOHAMMED ABDALQADER MD PHD

  • Medical Specialist of KPJ Healthcare
  • Lecturer at the International Medical School (IMS) of the Management and Science University (MSU)

Medical Specialties

Community Health, Family Health, Preventive and Regenerative Medicine, General Health


Honours

Dr Mohammed is a medical doctor specialising in community health and family health. He has comprehensive knowledge on general health due to his extensive teaching experience in both the Middle East and Asia. He has also studied and conducted many research on autism spectrum disorder (ASD), hypertension, depression and other chronic diseases.

Besides, he is greatly concerned about the malnutrition issues of his hometown, Baghdad City.

He believes that cellular therapy can ultimately prevent and cure every disease.

Close

PROF* DR HARRY YEO KAR KIAT

  • Head of Medical Unit of ZÉLL-V
* Title of (Visiting) Professor in Radiation Sciences while previously serving as part of a technical committee under a key Malaysian government national agency

Medical Specialties

Clinical Medicine, Cellular Biology & Radiation Sciences, Clinical Research, Preventive/Cancer/Palliative Medicine


Honours

MBBS (Sydney), C.UGClinRes (Oxford), Cand DPhil (Oxford), Harvard Medical School (USA), SpDipRadBio (Eur), SpDipRTPhys (Eur),
ESMO Academy (Oxford), SpT RadOnc (CF level, Australia), Adv SpT Pall Med (CF level, Australia), ESMO, ESTRO, ASCO (USA), TROG (AUST), NYAS (USA), MOS, MASP, MMA

*Warnings to General Public:- “The below classified information (Intellectual Property) is totally & fully protected & secured under the Law of Malaysia, and is subject to release to public viewing only & strictly under purview of personal information & copyright of the owner, who has absolute total legal rights & privileges under the Law of Malaysia. No one else other than The Owner/ The Company has any legal (lawfully given) rights to transfer, copy, snapshot or make photographic effort or share in any form the legally classified information below. Anyone who falsely attempts to use or claims or comments or takeover or interrupt or make or suggest or transform or transfer or link or share the below information in the form of any types of emails / SMS / Whatsapp / Wechat / Line / all social media platforms and etc without STRICT PERMISSION of the Owner/ The Company is strongly advised NOT TO DO SO as it is legally prohibited. Anyone or any entities who illegally has access to the above classified documents / in-depth information and illegally annouce, inform, publicize , distribute, share or disseminate the above information in any formats, without prior permission & recognition by THE OWNER / THE COMPANY and RELEVANT HEALTH AUTHORITIES OF MALAYSIA shall be deemed as CRIMINAL. The Criminal/s (who purposefully & willfully violate/s the above LAW or LEGAL RIGHTS OF THE OWNER/ THE COMPANY ) will be faced with jail terms, strong penalties and fines if found guilty under the JURISDICTION of MALAYSIA.”

______________________________________________________________________________________________
BIOGRAPHY
Prof* Dr Harry Yeo Kar Kiat’s Personal Biography

He graduated from Sydney University Medical School , MBBS (Sydney) in 2001;

He also obtained an undergraduate research certificate from Oxford University Medical School { C.UGClinRes (Oxford) } in the late 2000s while doing his Clinical Neurology research at the Radcliffe Infirmary of Oxford University;

He successfully completed one year compulsory housemanship at both venues : Sydney’s Concord Repatriation General Hospital of Australia and the General Hospital of Singapore, in 2001/02.

Officially became a fully qualified & registered medical doctor, both in Singapore & Australia in 2002;

Served as specialty registrar in Radiation Oncology @ Australian university hospitals from 2004 to 2006;

Successfully completed and awarded two specialist-level Diplomas in Radiation Oncology Basic Sciences { SpDip RadBio (Eur) & SpDip RTPhys (Eur) } organised by ESTRO based @ Europe (Belgium & Switzerland) in the late 2004s;

Appointed as Clinical Lecturer (Junior Level) in Radiation Oncology at an Australian University Medical School in 2005-2006;

Dr Yeo has become an Affiliated Member of the exclusive Australian and New Zealand cancer research Group since 2005;

Served as Advanced Trainee in Palliative Medicine (Clinical Fellow level) at major teaching university hospitals in Australia in 2007;

In 2005-2008, Dr Yeo became Member of 3 major medical specialty training faculties in Australia;

Unconditionally and legally registered as fully qualified doctor and voting member with Malaysian medical regulatory bodies since 2008.

Upon invitation and approval by relevant health authorities in Malaysia, he returned and served as Consultative Medical Officer (CMO) for Clinical Oncology Services at a key Malaysian Tertiary-Level governmental hospital in KL, Malaysia from 2008 to 2011;

During the same period of time, he was also appointed as Consultant Clinical Oncologist for Clinical Research Project: National Cancer Patient Registry (NCPR) , Clinical Research Centre (CRC), at a key Malaysian tertiary-level governmental hospital in KL, Malaysia from 2008 to 2011;

In 2009/10, he was selected as World Top 5% Doctorate Candidate in Radiobiology (Radiation Oncology) at the world-renowned Gray’s Institute, University of Oxford { Cand DPhil RadOnc (Oxford) } after highly competitive world-wide interview rounds — deferred till suitable time due to multiple factors;

He was appointed as an expert in capacity of (Visiting) Professor* of Radiation Sciences and also a Malaysian medical professional authority’s representative for Technical Committee at a key Malaysian national agency (2012-2014);

He was also offered on part-time basis as Candidate for Professional Doctorate in Public Health at Monash University (Malaysia Campus), { C DrGaPH (Monash) } from 2014 to 2022;

Successfully attended ESMO Academy (Pre-ESMO Fellowship Preparation Course) at Oxford, UK and obtained the highly regarded EACCME(Europe)/AMA (USA)/RCPSC (Canada)-endorsed medical specialist certificate {ESMO Academy } in 2015;

In 2016-17, Dr Yeo was a medical consultant cum clinical researcher heavily involved in Japanese-originated Clinical Cancer Immunotherapy Case Trial (Public-Private Partnership) at a local KL medical centre ; [Cancer Immunotherapy is widely regarded now as 4th Pillar of Cancer Treatments after Surgery, Radiotherapy and Drug/Chemotherapy, after two prominent scientists in cancer immunotherapy (from Japan & USA) won the 2018 Nobel Medicine Prize this year due to their ground breaking work in
anti-PD-1 & anti-CTLA4 immunotherapy ]

Due to his outstanding leadership qualities and contributions in medical / clinical services, Dr Yeo is the latest recipient of Harvard University Medical School (USA) Scholarship with official admission into the highly selective Harvard Medical
School-run Healthcare Leadership Programme in 2018/19;

Now He is a Full International Member for ESTRO, ESMO, ASCO and TROG (AUST),
NYAS (USA) since 2011.
_____________________________________________________________________________________________

*The above info was appropriately registered, recorded and classified by the relevant Health Authorities of Malaysia under the appropriate rules and regulations of the Law in Malaysia.* Anyone or any entities who illegally has access to the above classified documents / in-depth information and illegally annouce, inform, publicize , distribute, share or disseminate the above information in any formats, without prior permission & recognition by THE OWNER / THE COMPANY and RELEVANT HEALTH AUTHORITIES OF MALAYSIA shall be deemed as CRIMINAL. The Criminal/s (who purposefully & willfully violate/s the above LAW or LEGAL RIGHTS OF THE OWNER/ THE COMPANY ) will be faced with jail terms, strong penalties and fines if found guilty under the JURISDICTION of MALAYSIA.”

_____________________________________________________________________________________________
ROLES & RESPONSIBILITIES
Building on a strong academic background in Radiobiology / Cancer Medicine and Clinical Medicine, and close professional affiliations with 3 major Royal-statused medical specialist training faculties in Australia for nearly 20 years, Dr HK Yeo is a highly experienced senior clinician, researcher and healthcare leader in-designate in the fields of Cellular Biology and Sciences, Cellular Therapeutics, as well as Preventive Medicine (NCD & Cancer) with special interests in anti-ageing, regenerative and immunotherapeutic medicine. In some cases Dr HK Yeo practises cell therapy, which has repair and rejuvenation properties, to help his patients alleviate symptoms and signs of premature ageing, and to recover their vigour and vitality. He is the first in the medical world to suggest the causal link between “Suboptimal Health Conditions” and “Chronic Inflammation”, and their complexly intertwined pathophysiological mechanisms. He has established the first ZÉLL-V clinical research unit in Asia – the first clinical research unit of its kind in the world focusing on Southeast Asians. Presently, Dr HK Yeo is the Head of Medical Unit of ZÉLL-V overseeing the overall medical and clinical operations and development of some of the latest medical innovations. Dr Yeo is also a well sought-after guest speaker in many public forums and conferences around the world (especially the Asia Pacific region), relating to medical education, innovation, conceptual awareness and disease (NCD and cancer) prevention. He is now considered one of the most prominent young Asian healthcare leaders driving the concepts and ideas of futuristic medicine based on the 4th industrial revolution set by the World Economic Forum. Since 2015, Dr Yeo has been elected as one of the exclusive 5-member medical panels for a major local medical charity foundation (volunteer for service) in Malaysia.

_____________________________________________________________________________________________

Close

Dato’ Dr Nor Shahidah Khairullah

  • Medical Doctor (MBBS), University Malaya
  • Member of Royal College of Pathologist (MRCPath)
  • Fellowship from the Royal College (FRCPath)
  • Consultant Clinical Virologist
  • Aesthetics and Antiaging (AAAM/SAAARM/SAHAAM)

Medical Specialties

Virology, Pathology and Aesthetic Medicine


Honours

Dato’ Dr Nor Shahidah Khairullah obtained her medical degree from the University of Malaya in 1983 and continued her post-graduate education in Clinical and Molecular Virology at University of London’s School of Tropical Medicine and Hygiene in the United Kingdom. After obtaining her Masters in Clinical Virology in 1987, she was offered the British Commissioner’s Research award for her work in dengue vaccines.

She qualified as a Member of the Royal College of Pathologist (MRCPath) in 1994 and was awarded a Fellowship from The Royal College (FRCPath) in 1996. In addition to this, she is a Fellow of Academy of Medicine Malaysia (FAMM).

After 11 years of service as the Consultant Clinical Virologist and Academician in University Malaya Medical Centre (UMMC) she left in 1994 when she was offered by Specialty Laboratories USA to set up a high-end testing laboratory, the first in Malaysia.

In 1997, she was head hunted to join Eli Lilly Malaysia as their first Medical Director for Malaysia, Singapore and Brunei.

In 1998, she resigned to do charity work as the Chief Executive Officer of the Malaysian Liver Foundation, a charitable not for profit organization dedicated to the study of Hepatobiliary diseases and Liver Cancer through education, research, and training. During this time she was also consulting for Pharma Eli Lilly as their Clinical Research Physician in Asia Pacific and as an Expert in Infectious Disease and Vaccines for Glaxo Smith Kline.

Her other corporate past appointments include Medical Consultant for Pharma Sanofi Pasteur. She then left the company to resume her academic work as the Deputy Vice Chancellor for Research and Scientific Innovation as well as Dean of Post graduate studies at MAHSA University.

She was a member of the Technical Advisory Board for the Drugs for Neglected Diseases Initiative (DNDi) in Geneva, Switzerland for the past 6 years and was also a regional advisor representing the Ministry of Health for the World Health Organisation (WHO) and European Commission (EU) between 2002 until 2007.

In 2002, she started her work in cell therapy and later visited Dr Ben Pfeifer in Aeskulap Clinic, a Centre for Holistic Medicine in Brunnen, Switzerland.

In 2007, she was awarded the Royal Award, Dato Paduka Mahkota Perak by the Sultan of Perak for her work during the SARs outbreak.

In 2012 she was offered the post of Corporate Director of Medical Services by Villa Medica Asia, the Asian counterpart of the Regenerative Medicine Group of Clinics (main clinic is Villa Medica Germany in Edenkoben). She created the medical services menu for Villa Medica Asia and assisted in the harvesting and preparation of foetal sheep cells and treatment of patients in the clinic in Germany.

She is a Board Certified physician in Aesthetic Medicine and Anti-Aging Medicine by the American Association of Aesthetic Medicine (AAAM) as well as the World Society of Anti-Aging Medicine (WOSAAM). She is a member of the National Committee for Credentialing and Privileging for Aesthetic Medical Practice in the Ministry of Health and has been appointed as a member of the Curriculum Committee for Aesthetic Medical Practice.

Dato’ Dr Nor believe that “Beauty is from the Inside Out “ and that healthcare should also be addressing root causes of diseases instead of only alleviation of symptoms and that approaches to medicine should include Energy Medicine and traditional practices such as Meditation and Yoga. She pursued these studies until she is qualified as a master in Meditation and Reiki as well as life coaching.

She then started her part-time practice in Regenerative, Aesthetics and Functional Medicine in Global Doctors Specialist Centre (Hospital) in Mont Kiara Kuala Lumpur until recently when she devoted more time to set up an Integrative, Preventive and Wellness clinic for the Malaysian Liver Foundation.

She has been the Chief Executive Officer of the Malaysian Liver Foundation for the past 20 years and the Medical Director and Founder of the Molecular Research Laboratory (the only NGO lab that is NATA accredited) for the past 16 years since it was formed.

Dato’ Dr Nor has been involved in Clinical Research as well as the National Ethics Board of the Ministry of Health. She is a member of many professional bodies including the Society for Anti-Ageing and Regenerative Medicine (SAAARM) as well as a Board and Founding Member of the Society for Advancement of Hormones and Healthy Ageing (SAHAAM). She is the Past President of the Asia Pacific Travel and Health Society.

Dato’ Dr Nor Shahidah has been involved in a number of international trials for the treatment and management of chronic hepatitis B and chronic hepatitis C including herbal therapy for HIV and Hepatitis, Editor for Liver News, the official newsletter of the Malaysian Liver Foundation as well as the Malaysian Astrological Society. She had supervised several MSc and PhD students and reviewed many scientific manuscripts.

She has been involved as the Organising Committees and as Invited Speaker in various regional and local congresses in Integrative, Anti-Ageing and Aesthetic Medical Practice as well as Infectious Diseases. Dato’ Dr Nor has 59 publications in Medical Journals.